4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.

• J. Jacobson,
• B. Sleebs,
• K. Jarman,
• W. Nguyen,
• T. Mota,
• L. Harty,
• G. Khoury,
• N. Tay,
• P. Cameron,
• S. Lewin,
• D.F.J. Purcell

Affiliations

J. Jacobson

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

B. Sleebs

Walter and Elisa Hall Institute, Parkville, Australia

K. Jarman

Walter and Elisa Hall Institute, Parkville, Australia

W. Nguyen

Walter and Elisa Hall Institute, Parkville, Australia

T. Mota

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

L. Harty

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

G. Khoury

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

N. Tay

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

P. Cameron

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

S. Lewin

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia

D.F.J. Purcell

Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia